Drug combinations for reducing cell viability and/or cell proliferation
US11357769B2 · kind B2 · utility
0Cited by
5References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2017 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | May 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/3955
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a combination of agents for reducing cell viability and/or cell proliferation. The combination comprises an FGFR4 inhibitor and an EGFR inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.